Our Services for Highly Potent & Controlled Substances  

Whether it’s highly concentrated active pharmaceutical ingredients (APIs), chemicals or naturally sourced controlled substances, our facilities offer full-scale solutions from clinical to commercial production. With our full cGMP facilities and capabilities, we ensure quality, consistency and compliance throughout the active compound development lifecycle and are supported by the following licences: 

  • Health Canada Drug Establishment License  
  • Health Canada Licenses for Restricted Substances 
  • Health Canada License for Natural Health Products  
  • Health Canada Cannabis License 
20211020 API 0643

Services Overview

Potent Compound Synthesis

Specialized manufacturing of highly potent chemicals, APIs and natural health products for clinical and commercial use.

Pre-Clinical and Clinical Manufacturing: 

Tailored solutions for preclinical and early-stage clinical manufacturing with scalable, GMP-compliant procedures. 

cGMP Production

State-of-the-art cGMP laboratories supporting the full development cycle of highly active and regulated compounds.

Stability Studies

Robust stability testing and monitoring under various environmental conditions.

Did you find the service that meets your needs?

Start your journey with us.

Get In Touch

Contract Development Manufacturing Services & Facilities 

Clinical Trial Manufacturing

We offer adaptable, high-quality clinical trial manufacturing for small molecule therapeutics, supporting seamless transition from preclinical research through late-stage development. Our phase appropriate GMP facilities—the Drug Development and Innovation Centre on the Katz Group Centre at the University of Alberta and the Biotechnology Business Development Centre (BBDC)—are purpose-built to enable efficient small-batch production, process optimization, quality control testing and stability studies.

  • Biotechnology Business Development Centre (BBDC)

    • R&D manufacturing from clinical to commercial GMP production 
    • Auxiliary R&D lab for formulation and optimization 
    • Specialized containment and processing equipment including 
      Buchi Glas Reactors, Nutsche Filters and Gas Scrubber
  • Drug Development & Innovation Centre (Katz Group Centre)

    • Small-scale small molecule production (up to 10 kg batches) 
    • Small molecule API production for clinical phase I and II 
    • Formulation prototyping for various forms of highly potent substances 

Why Highly Potent & Controlled Substances Require Specialized Expertise

The production of highly potent and controlled substances is a critical area of pharmaceutical manufacturing—for good reason:

  • Precision is Vital: Highly potent substance production involves intricate, multi-step chemical processes, where exacting precision is essential to ensure potency, purity, and safety.  
  • Expertise, Quality, and Compliance are Essential: Manufacturing these substances demands specialized knowledge—from handling raw materials and optimizing reactions to refining purification, formulation, and analytical testing—all while adhering to strict GMP standards and regulatory requirements. 
  • Partnering with the right process expert is crucial, as they can guide the entire process—from early-stage development and scale-up to regulatory support and commercial production. 
20211020 API 0717

Meet Our Senior Leaders and Contacts

Allan Aginski
Member Highlight Hans Bauer
Shawn Couch
Vijay Somayaji

End-to-End Manufacturing Support

We provide comprehensive manufacturing solutions from preclinical stages to large-scale commercial production. Our integrated approach, combined with our Early Discovery & Development, Regulatory and Quantitative Solutions (QS) teams, ensures a seamless experience at every step of the development journey. 

Discover CRO Services
K&R 24 765 (1)